MedTrace Logo

A Study to Promote Physical Activity Motivation in Cardiovascular Disease Patients

NCT05867511 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2023-11-28

No results posted yet for this study

Summary

This study investigates the feasibility of an app based intervention, which uses questionnaires and personalized motivational messages to achieve change in physical activity and sedentary behaviour of cardiovascular patients. The questionnaires and messages are based on behaviour change theories, such as the transtheoretical model. The intervention will take place over eight weeks. One week before and during the last week, physical activity will be measured via accelerometers. A comprehensive questionnaire will be given before and at the end of the intervention and Feasibility measures will be evaluated at the end as well, including an optional qualitative interview with the participants.

Conditions

Interventions

BEHAVIORAL

iPAL App

The intervention will have a duration of eight weeks. It is theory-based, will be delivered to participants' smartphones via the study app (except components 5 and 6), and comprises the following components: 1. Theory-based individualized feedback. 2. Self-generated motivational messages. 3. Motivation for habit formation through push messages. 4. Motivational images and videos that participants handed in or selected will be sent to them through the app. 5. Study-specific social media groups. Participants will be offered the option to participate in study-specific social media groups. 6. Posting motivational stories. A story of a person, who successfully changed his or her lifestyle to be more physically active and/or less sedentary, will be posted once a week in the study-specific social media groups.

Sponsors & Collaborators

  • University of Bern

    collaborator OTHER

  • Claudio Nigg

    lead OTHER

Principal Investigators

  • Claudio Nigg, PhD · University of Bern

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-06-30
Completion
2023-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05867511 on ClinicalTrials.gov